EcoDrugPlus

Prostaglandin F Receptor

Ensembl ID : ENSCDRG00005014602
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSCDRG00005012366
Gene Symbol: PTGIR
3 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSCDRG00005008480
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSCDRG00005016525
Gene Symbol: PTGS2
3 Cross references
240 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSCDRG00005017399
Gene Symbol: PSMA1
3 Cross references
234 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSCDRG00005003904
Gene Symbol: PSMA3
3 Cross references
246 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSCDRG00005019152
Gene Symbol: PSMA4
3 Cross references
249 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSCDRG00005002587
Gene Symbol: PSMA5
3 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSCDRG00005017112
Gene Symbol: PSMA6
3 Cross references
268 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSCDRG00005004975
Gene Symbol: PSMA7
3 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSCDRG00005017287
Gene Symbol: PSMA8
3 Cross references
198 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSCDRG00005018457
Gene Symbol: PSMB1
3 Cross references
217 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).